Cargando…

Biomarkers in acute graft-versus-host disease: new insights

Hematopoietic cell transplantation (HCT) is a potentially curative therapy for hematologic malignancies that relies on the graft-versus-leukemia (GVL) effect to eradicate malignant cells. GVL is tightly linked to graft-versus-host disease (GVHD) however, in which donor T cells damage healthy host ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srinagesh, Hrishikesh K., Levine, John E., Ferrara, James L.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893923/ https://www.ncbi.nlm.nih.gov/pubmed/31839920 http://dx.doi.org/10.1177/2040620719891358

Ejemplares similares

3424 Serial Biomarker Monitoring Predicts Long Term Outcomes in Acute Graft Versus Host Disease
por: Srinagesh, Hrishikesh Krishna, et al.
Publicado: (2019)

New Insight for the Diagnosis of Gastrointestinal Acute Graft-versus-Host Disease
por: Malard, Florent, et al.
Publicado: (2014)

New insights into the basic biology of acute graft-versus-host-disease
por: Li, Alicia, et al.
Publicado: (2020)

Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis
por: Reddy, Pavan, et al.
Publicado: (2001)

Acute graft versus host disease
por: Jacobsohn, David A, et al.
Publicado: (2007)

Graft-versus-host disease: establishing IL-33 as an important costimulatory molecule
por: Ferrara, James, et al.
Publicado: (2022)

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2020)

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
por: Fiema, Bryan, et al.
Publicado: (2012)

Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease
por: Kanaya, Minoru, et al.
Publicado: (2016)

Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
por: Robin, Marie, et al.
Publicado: (2022)

Translational and clinical advances in acute graft-versus-host disease
por: Gooptu, Mahasweta, et al.
Publicado: (2020)

Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease
por: Martin, Paul J., et al.
Publicado: (2021)

Advances in the treatment of acute graft-versus-host disease
por: Qian, Liren, et al.
Publicado: (2013)

Graft versus host disease: New insights into A(2A) receptor agonist therapy
por: Jones, Karlie R., et al.
Publicado: (2014)

Murine Models Provide New Insights Into Pathogenesis of Chronic Graft-Versus-Host Disease in Humans
por: Song, Qingxiao, et al.
Publicado: (2021)

Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?
por: Zhao, Xiao-Su, et al.
Publicado: (2019)

Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease
por: Abboud, Ramzi, et al.
Publicado: (2020)

Acute Graft Versus Host Disease After Kidney-Pancreas Transplant
por: Lopez, James, et al.
Publicado: (2023)

Granulysin-Bearing Cells in the Skin Lesions of Acute Graft-versus-Host Disease: Possible Mechanisms for Hypohidrosis in Graft-versus-Host Disease
por: Furudate, Sadanori, et al.
Publicado: (2013)

A combined biomarker and clinical panel for chronic graft versus host disease diagnosis
por: Pidala, Joseph, et al.
Publicado: (2016)

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease
por: Pratta, Michael, et al.
Publicado: (2022)

The role of B cells in acute graft-versus-host disease
por: Cho, Byung-Sik, et al.
Publicado: (2011)

The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease
por: Chen, Yuanyuan, et al.
Publicado: (2015)

Acute Graft-Versus-Host Disease: A Brief Review
por: Aladağ, Elifcan, et al.
Publicado: (2020)

Endothelial damage and dysfunction in acute graft-versus-host disease
por: Cordes, Steffen, et al.
Publicado: (2020)

Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease
por: Akahoshi, Yu, et al.
Publicado: (2022)

PET assessment of acute gastrointestinal graft versus host disease
por: Scott, Ashleigh P., et al.
Publicado: (2023)

Data-driven grading of acute graft-versus-host disease
por: Bayraktar, Evren, et al.
Publicado: (2023)

Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate
por: Han, Jingjing, et al.
Publicado: (2017)

EBMT—NIH—CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
por: Schoemans, Helene M., et al.
Publicado: (2018)

Insights into mechanisms of graft-versus-host disease through humanised mouse models
por: Elhage, Amal, et al.
Publicado: (2022)

Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

Microbiome: an emerging new frontier in graft‑versus‑host disease
por: Kumari, Reena, et al.
Publicado: (2020)

Validation of Minnesota acute graft-versus-host disease Risk Score
por: MacMillan, Margaret L., et al.
Publicado: (2020)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
por: Cheung, Tik Shing, et al.
Publicado: (2020)

Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death
por: Logan, Brent R., et al.
Publicado: (2023)

The Nlrp3 inflammasome regulates acute graft-versus-host disease
por: Jankovic, Dragana, et al.
Publicado: (2013)

NOTCH and Graft-Versus-Host Disease
por: Di Ianni, Mauro, et al.
Publicado: (2018)

IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects
por: Liu, Yuejun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rjlppsj7a8gckq6tppvsasvc59